Heaves hit for Stirling
Tuesday, 29 July, 2008
Stirling Products [ASX: STI] has been granted an Australian patent or the treatment of heaves in horses with R-salbutamol.
The company has already been granted a patent for the same concept from South Africa, and Stirling representatives say they expect more grants to follow shortly.
A patent application for the inhaler device developed to help administer the drug, the Equinehaler, has also been lodged.
Heaves, also known as recurrent airway obstruction, affects an estimated 25-30 per cent of all horses in Europe and the US.
Stirling is also looking at using R-salbutamol - a highly purified version of salbutamol, better known as Ventolin - as a growth agent and as a treatment of obesity in dogs.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
